Our scientists and technical staff have over 20 years of experience with a diverse range of therapeutics, including biologics, small molecules, gene therapy and cell therapy for ocular indications, and the ability to administer these agents via both common and novel ocular dose routes.

In addition, we offer supplementary services for your ocular program, including optical coherence tomography (OCT), electroretinography (ERG), tonometry (IOP), digital fundus photography, pachymetry (corneal thickness measurement), vitrectomy, quantitative autoradiography, drug metabolism techniques and enhanced microscopic evaluation.

  • Glaucoma (normotensive and hypertensive)
  • Anterior uveitis
  • Age-related macular degeneration (AMD)
  • Corneal neovascularization
  • Diabetic retinopathy
  • Neuroprotection model
  • In vitro human corneal epithelium (HCE)
  • Topical instillation
  • Intravitreal
  • Internal/external implants and transplants
  • Subretinal injections
  • Intracameral injections
  • Subconjunctival injections
  • Subtenon injections

You may also be interested in...

Fluorescein angiography laser CNV lesions

Ocular Imaging Poster Presentation

This poster describes ocular imaging techniques, such as optical coherence tomography, specular microscopy and fundus autofluorescence.

Anterior Chamber SD-OCT

Find out more on our latest imaging technique that can be applied to safety assessment studies of ocular therapeutics and therapeutics which affect the eye.

Together We See a Cure

Watch a video highlighting our integrated approach to ophthalmology research, every step of the way.

scientist at a computer

Ocular Webinar Replay

This webinar provides an overview of the ocular capabilities and experience at Charles River, including rodent and nonrodent pharmacology models and safety assessment for regulatory submission.